GSA Capital Partners’s POINT Biopharma Global Inc. Common Stock PNT Stock Holding History

GSA Capital Partners’s Portfolio PNT Stock Details PNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-13,987	Closed	-$93K	–	2033
2023 Q3	$93K	Sell	13,987 -31,297	-69%	-$260K	0.01%	1393
2023 Q2	$410K	Buy	45,284 +33,220	+275%	+$293K	0.04%	856
2023 Q1	$88K	Buy	+12,064	New	+$89.5K	0.01%	1373

Other funds holding PNT

BTI

Blue Trust Inc Alpharetta, Georgia $9.54B AUM 19.86% 1-Year Est. Return

GSA Capital Partners's PNT Position: Q4 2023 in Review

GSA Capital Partners sold out of POINT Biopharma Global Inc. Common Stock (PNT) in Q4 2023, closing a stake of 13,987 shares — an estimated $93K sold.

GSA Capital Partners first reported a position in PNT in Q1 2023 and held it in 3 quarters. The position peaked at $410K in Q2 2023. 1 fund tracked by Wall St. Rank holds PNT as of Q4 2023.

GSA Capital Partners reported no remaining POINT Biopharma Global Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
GSA Capital Partners sold 13,987 POINT Biopharma Global Inc. Common Stock shares in Q4 2023, an estimated $93K.
GSA Capital Partners first reported a position in POINT Biopharma Global Inc. Common Stock in Q1 2023 and held it in 3 quarters.
GSA Capital Partners's POINT Biopharma Global Inc. Common Stock position peaked at $410K in Q2 2023.
1 fund tracked by Wall St. Rank held POINT Biopharma Global Inc. Common Stock as of Q4 2023.

Based on GSA Capital Partners's 13F filing for Q4 2023, filed 16 Feb 2024.